iURO Kidney Lite vs NCCN Guidelines®

iURO Kidney is the must-have app for all urology and nephrology healthcare professionals and students. The narrated simulation videos make it easy to understand and explain the different pathologies and therapies. It can be used by doctors and nurses to enhance communication with their patients. Medical students can use iURO apps to increase their knowledge and understanding of various urological topics. iURO Kidney can also be used by patients directly, to familiarize themselves with the different aspects of their urological condition and the treatment options available. Features include: •Narrated simulation videos to explain the kidney functions •Narrated simulation videos to explain kidney stone pathologies •Narrated simulation videos to explain different treatment options •Draw on picture, offering the opportunity to draw on and make personalized notes on a 3D image •Send this customized 3D image directly to patients or colleagues by email •360º image of the kidney, offering the opportunity to zoom on the 3D image from every angle iURO apps are created in consultation with urologists in order to provide a realistic representation of pathologies and therapies. iURO apps are prepared with the aim of enhancing communication and education options. If you are not a healthcare professional, please note that iURO apps support but never substitute the relation with your healthcare professional. App Management: •Scientific Director: Carlos Rioja, Hospital Royo Villanova, Zaragoza, Spain •Scientific Director: Jorge Rioja, Hospital Miguel Servet, Zaragoza, Spain •Scientific Director: Sanjeev Bandi, Mackay Urology, Mackay Australia iURO Scientific Advisory Board: Lithiasis •Olivier Traxer, University Pierre et Marie Curie Paris, France •Adrian Joyce, Spire Leeds Hospital in Roundhay, Leeds, Yorkshire, United Kingdom Benign Prostatic Hyperplasia •Jean de la Rosette, AMC University Hospital, Amsterdam, The Netherlands •Matthias Oelke, Hanover Medical School, Hanover, Germany Pelvic Floor Disorder, Functional and Female Urology •David Castro, University of La Laguna, Tenerife, Spain •Dirk De Ridder, Kliniekhoofd Urologie UZ, Leuven, Belgium Oncology •Karim Touijer, Memorial Sloan Kettering Cancer Center, New York, USA •Raul Parra, Memorial Sloan Kettering Cancer Center, New York, USA •Peter Scardino, Memorial Sloan Kettering Cancer Center, New York, USA •Pilar Laguna, AMC University Hospital, Amsterdam •Sharokh Shariat, Weill Medical College of Cornell University, New York, USA •Theo de Reijke, AMC University Hospital Amsterdam, The Netherlands •Octavio Castillo Cadiz, Clínica Indisa, Santiago, Chile •Jaime Landman, University of California Irvine, Los Angeles, USA Andrology •Eduard Garcia, University Hospital Clícic de Barcelona, Barcelona, Spain •Juan Ignacio Martinez Salamanca, University Hospital Puerta de Hierro Majadahonda, Autonomous University of Madrid, Madrid, Spain •Ignacio Moncada, Hospital La Zarzuela, Madrid, Spain •David J Ralph, St Peter’s Andrology Centre, London, United Kingdom •Nelson Bennett, Lahey Hospital and Medical Center, Burlington, USA •Rados Djinovic, Sava Perovic Foundation, Belgrade, Serbia

The National Comprehensive Cancer Network® (NCCN®), is pleased to present the Virtual Library of NCCN Guidelines® app formatted for iPhone & iPad. This easy-to-use and convenient format will further assist health care professionals in their implementation of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), thus improving the quality and effectiveness of care provided to patients with cancer. NCCN is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world. Over the past 25 years, NCCN has developed an integrated suite of tools to improve the quality of cancer care. The NCCN Guidelines® document evidence-based, consensus-driven management to ensure that all patients receive preventive, diagnostic, treatment, and supportive services that are most likely to lead to optimal outcomes. The NCCN Guidelines are a comprehensive set of guidelines detailing the sequential management decisions and interventions that apply to 97 percent of cancer cases in the United States. In addition, separate guidelines relate to major prevention and screening topics and another set of pathways focuses on the major supportive care areas. The NCCN Guidelines provide recommendations based on the best evidence available at the time they are derived. Because new data are published continuously, it is essential that the NCCN Guidelines also be continuously updated and revised to reflect new data and new clinical information. The intent of the NCCN Guidelines is to assist in the decision-making process of individuals involved in cancer care—including physicians, nurses, pharmacists, payers, patients and their families—with the ultimate goal of improving patient care and outcomes. The NCCN Guidelines provide recommendations for appropriate care for most but not all patients; however, individual patient circumstances must be considered when applying these recommendations. Visit NCCN.org to learn more about the NCCN Guidelines as well as other NCCN Content.